# EDGAR Filing Document

**Accession Number:** 0001790169
**File Stem:** 0001477932-23-000049
**Filing Date:** 2023-1
**Character Count:** 5494
**Document Hash:** c63e0375251e6714f6db8d9760fe1870
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-23-000049.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001477932-23-000049

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230101

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** MERCHAN LUIS
- **CENTRAL INDEX KEY:** 0001942445

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40397
- **FILM NUMBER:** 23502169

**MAIL ADDRESS:**
- **STREET 1:** C/O FLORA GROWTH CORP.
- **STREET 2:** 3405 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Flora Growth Corp.
- **CENTRAL INDEX KEY:** 0001790169
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3406 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312
- **BUSINESS PHONE:** 416-861-2267

**MAIL ADDRESS:**
- **STREET 1:** 3406 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>MERCHAN LUIS<br><sub>(Last) (First) (Middle)</sub><br>C/O FLORA GROWTH CORP.<br>3405 SW 26TH TERRACE, SUITE C-1<br><sub>(Street)</sub><br>FORT LAUDERALE, Z4 M5H 2V1<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Flora Growth Corp. [ FLGC ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-01-05:00 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_CEO & Chairman of the Board_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Shares<sup>(1)</sup> | 1975149<sup>(2)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Options (Right to Buy) | <sup>(3)</sup> | 2025-11-04-05:00 | Common Shares | 666666 | $2.25 | D |  |
| Options (Right to Buy) | <sup>(3)</sup> | 2026-12-16-05:00 | Common Shares | 125000 | $2.04 | D |  |
| Options (Right to Buy) | <sup>(4)</sup> | 2026-01-01-05:00 | Common Shares | 367347 | $0.67 | D |  |

---

### Footnotes:

(1) These Common Shares contain restricted share grants to the Reporting Person by the issuer as further described in footnote (2) below.

(2) The Common Shares reported include the following Restricted Common Shares (i) 102,040 shares which vest on July 5, 2023, (ii) 328,358 shares which vest on July 5, 2024 and (iii) 468,085 shares which vest on July 5, 2025.

(3) These options are immediately exercisable.

(4) These options shall vest if (i) the total shareholder return of the Issuer's Common Shares on the Nasdaq Capital Market exceeds the total shareholder return on the ETFMG Alternative Harvest ETF for the 12 months ended December 31, 2023, which shall be measured on December 31, 2023 or (ii) the total shareholder return of the Issuer's Common Shares on the Nasdaq Capital Market exceeds the total shareholder return on the ETFMG Alternative Harvest ETF for the 12 months ended December 31, 2024, which shall be measured on December 31, 2024.

**Signature:** /s/ Matthew Cohen, Attorney-in-Fact for Luis Merchan  
**Date:** 2023-01-03-05:00

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**